Heerlen, NL, 03 Nov 2009 07:15 CET
Commenting on the results, Feike Sijbesma, chairman of the DSM Managing Board, said: “DSM delivered strongly improved results for Q3 2009, with ongoing resilience in Nutrition and a further improvement in Materials Sciences compared to the previous quarters. Our early action to reduce costs, our focus on cash and our commitment to innovation and China are paying off.
“We are alert that the economic climate remains uncertain and that the path of recovery is likely to prove uneven. However, it seems that the first half of 2009 represented the low point for this recession and we are showing that we are well placed to capitalize as markets improve, which is also reflected in a strong sales volume development.
“Throughout these challenging times, DSM is staying the course. We completed the disposal of two non-core businesses and remain committed to exiting the remaining non-core operations. Our strategic commitment to create a Life Sciences and Materials Sciences company addressing important global trends via a focus on customers, innovation and sustainability is undiminished. Our robust financial strength allows us to capture market opportunities as they arise.”
|Q3 2009||Q3 2008||+/-||in € million||Jan - Sep 2009||Jan - Sep 2008||+/-|
|257||361||-29%||Operating profit before depreciation & amortization (EBITDA)||562||1,011||-44%|
|139||237||-41%||Operating profit (EBIT)||229||685||-67%|
|2||85||-98%||Base Chemicals and Materials||-60||158|
|26||34||-24%||Operating profit before depreciation & amortization (EBITDA)||80||105||-24%|
|26||30||-13%||Operating profit (EBIT)||72||95||-24%|
|165||267||-38%||Operating profit (EBIT)||301||780||-61%|
|100||181||-45%||Net profit before exceptional items||155||535||-71%|
|274||Net result from exceptional items||242|
|Net earnings per ordinary share in €:|
|0.51||0.97||-47%||before exceptional items, continuing operations||0.62||2.78||-78%|
|2.29||1.10||108%||including exceptional items, total DSM||2.40||3.20||-25%|
You can find the press release in full, including financial statements, below.